We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Recurrent renal disease after renal transplantation.
Current Opinion in Nephrology and Hypertension 1994 November
Recurrent disease does not lead to the loss of large numbers of allografted kidneys, but it is a source of serious concern in recipients with type I hyperoxaluria and focal segmental glomerulosclerosis. In patients with a number of other causes of renal failure, it may affect the use of living related donors. Recent topics for debate include the failure of cyclosporine to modify the incidence of recurrent disease, the realization that IgA nephropathy may in the long term lead to graft destruction, the fact that membranous nephropathy may recur in a quarter of the cases, and the knowledge that a nephrotic syndrome may reappear after transplantation for the Finnish congenital nephrotic syndrome.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app